Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Thrive app
BEHAVIORAL
2 trials
Sponsors
Emory University
, Hospital de Clinicas de Porto Alegre
Conditions
Breast Neoplasm Female
Depressive Disorder, Major
Unknown Phase
THRIVE Breast Cancer App Study
Completed
NCT03592771
Emory University
Breast Neoplasm Female
Start: 2018-11-15
End: 2022-06-30
Updated: 2023-09-05
Smartphone App Based CBT Versus Online Group CBT: Randomized, Non-inferiority Clinical Trial
NCT05450614
Hospital de Clinicas de Porto Alegre
Depressive Disorder, Major
Start: 2022-08-01
End: 2023-12-31
Target: 200
Updated: 2022-07-11
Related Papers
Adherence to oral endocrine therapy by menopausal status: post hoc insights from a remote monitoring randomized trial
npj Breast Cancer
2026-01-28
Racial Differences in Symptom Burden and Endocrine Therapy Adherence in Breast Cancer: A Post Hoc Analysis of a Randomized Trial
Journal of the National Comprehensive Cancer Network
2025-09-26
1 citations
Addressing health literacy gaps in adjuvant endocrine therapy adherence: Post hoc insights from a randomized remote monitoring trial.
2025-08-05
1 citations
<scp>COVID</scp>‐19‐Related Financial Hardship and Adherence to Adjuvant Endocrine Therapy Among Women With Early‐Stage Breast Cancer
Health Services Research
2025-06-17
1 citations
Digital interventions for depressive symptoms: a randomized clinical trial.
2025-05-11
Understanding health literacy's moderating role in remote monitoring for adjuvant endocrine therapy: Findings from a randomized clinical trial.
JCO Oncology Practice
2024-09-30
Remote Monitoring App for Endocrine Therapy Adherence Among Patients With Early-Stage Breast Cancer
JAMA Network Open
2024-06-27
17 citations
Abstract 4836: Race differences in symptom burden and medication adherence among women with breast cancer on adjuvant endocrine therapy: A post hoc analysis of a randomized control trial
Cancer Research
2024-03-22
1 citations
A randomized controlled trial of a mobile app and tailored messages to improve outcomes among women with breast cancer receiving adjuvant endocrine therapy.
Journal of Clinical Oncology
2023-06-01
3 citations
THRIVE study protocol: a randomized controlled trial evaluating a web-based app and tailored messages to improve adherence to adjuvant endocrine therapy among women with breast cancer
BMC Health Services Research
2019-12-01
26 citations